FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements-Reference-Cited by-同舟云学术

FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements

Published:2018-02 Issue:2 Volume:56 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Lutgring Joseph D.¹²,Machado María-José¹,Benahmed Faiza H.³,Conville Patricia³,Shawar Ribhi M.³,Patel Jean¹,Brown Allison C.¹

Affiliation:

1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA

3. Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, USA

Abstract

ABSTRACT The FDA-CDC Antimicrobial Resistance Isolate Bank was created in July 2015 as a publicly available resource to combat antimicrobial resistance. It is a curated repository of bacterial isolates with an assortment of clinically important resistance mechanisms that have been phenotypically and genotypically characterized. In the first 2 years of operation, the bank offered 14 panels comprising 496 unique isolates and had filled 486 orders from 394 institutions throughout the United States. New panels are being added.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01415-17

Reference15 articles.

1. Antibiotic Misuse

2. Centers for Disease Control and Prevention Office of Infectious Diseases. 2013. Antibiotic resistance threats in the United States 2013. Centers for Disease Control and Prevention Office of Infectious Diseases Atlanta GA. http://www.cdc.gov/drugresistance/threat-report-2013. Accessed 19 May 2017.

3. The United Nations and the Urgent Need for Coordinated Global Action in the Fight Against Antimicrobial Resistance

4. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

5. The emergent needs for basic research, education, and surveillance of antimicrobial resistance

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin;Journal of Controlled Release;2024-01

2. A Candida auris –specific adhesin, Scf1 , governs surface association, colonization, and virulence;Science;2023-09-29

3. Development of an Imaging Flow Cytometry Method for Fungal Cytological Profiling and Its Potential Application in Antifungal Drug Development;Journal of Fungi;2023-06-30

4. The carbapenem inoculum effect provides insight into the molecular mechanisms underlying carbapenem resistance inEnterobacterales;2023-05-23

5. Generation of Synthetic Acinetobacter baumannii-Specific Nanobodies;ACS Infectious Diseases;2023-05-10